Carol Elizabeth 618 Posted August 30, 2018 Posted August 30, 2018 Hi all - I am new here - diagnosed April - scan was done for another surgery.. biopsy showed EGFR mutation - stage 3a - non operable - none symptomatic- treatment done ✅- 44 radiation and chemo concurrently- did my 5 week rest , petscan tomorrow- last appointment showed tumor was 75 percent eradicated . Would like to hear from other stage 3 survivors and hear about your journey-
Donna G Posted August 30, 2018 Posted August 30, 2018 Hello Carol Elizabeth and welcome. I was stage 3B.. I was diagnosed in December 1997. They did not test for EGRF back then. I started with chemos and radiation. Because it shrunk up I did have my right upper lobe removed then I got more chemo. I survived. Hope your pet scan has great results tomorrow , please let us know ! Donna G
Carol Elizabeth 618 Posted August 31, 2018 Author Posted August 31, 2018 Thank you Donna - I find out on the 7th - will update
Tom Galli Posted August 31, 2018 Posted August 31, 2018 Welcome Carol Elizabeth! Stage IIIB NSCLC Squamous cell here. Pre surgical radiation & Taxol and Carboplatin, then pneumonectomy, then surgical complications beget more surgery. Tumors found in my remaining lung. 12 more infusions of Taxol & Carboplatin. One tumor persisted and was fried by CyberKnife. Diagnosed February 4, 2003. Journey was a pain but have been NED since March 2007 and am as active as an elderly gent with one lung can be. I really hope your scan is NED. Stay the course. Tom
LexieCat Posted August 31, 2018 Posted August 31, 2018 Hi, Carol! Just wanted to welcome you here--glad you've connected already with a couple of our Stage III heroes. I was lucky enough to be Stage Ib, so I don't have any relevant treatment experience to share. Good luck with your scan today--will look forward to your update. Glad you found us!
Carol Elizabeth 618 Posted August 31, 2018 Author Posted August 31, 2018 Thank you all - will keep you in the loop
Recommended Posts
Archived
This topic is now archived and is closed to further replies.